Wave Life Sciences shares plunged over 55% on Thursday after a higher dose of its experimental obesity drug failed to show a ...
Wave Life Sciences Ltd. (NASDAQ:WVE) shares fell 30% Thursday following the company’s announcement of interim Phase 1 data ...
Loomis Sayles, an investment management company, released its fourth-quarter 2025 investor letter for “Small Cap Growth Fund” ...
W hile challenges persist in the short term, there are signs pointing toward long-term growth for life sciences, according to JLL’s 2024 Life Sciences Real Estate Perspective and Cluster Analysis. The ...
Read about the new Biocom Octane partnership. Discover how this collaboration expands capital and accelerator access for ...
Q4 2025 Management View Richard A. Stewart, President, CEO & Executive Director, emphasized the company's transition from a clinical-stage to a commercially focused enterprise following the NDA ...
T he U.S. life sciences real estate market posted positive net absorption in the fourth quarter even as robust construction completions raised the sector’s vacancy rate to 19.7%, according CBRE’s new ...
Despite world-class AI-biotech research, a Nobel Prize-winning protein design lab and proximity to global AI expertise, ...
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...
Ed Field is President of BioLabs NC. Mr. Field has 20+ years c-level experience in building and selling numerous early-stage and publicly-traded biotechnology companies. He has been responsible for ...
William “Bill” McKeon is the President and Chief Executive Officer of the Texas Medical Center. He is responsible for driving strategic, operational and programmatic initiatives across the Texas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results